Aclidiniumbromid forbedrer lungefunktion og reducerer åndenød hos patienter med KOL
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Aclidiniumbromid forbedrer lungefunktion og reducerer åndenød hos patienter med KOL. / Ulrik, Charlotte Suppli.
In: Ugeskrift for Laeger, Vol. 176, No. 28, 31.03.2014, p. 1296-1299.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Aclidiniumbromid forbedrer lungefunktion og reducerer åndenød hos patienter med KOL
AU - Ulrik, Charlotte Suppli
PY - 2014/3/31
Y1 - 2014/3/31
N2 - Long-acting bronchodilators are central for treatment of COPD. This short review provides an overview of studies evaluating the efficacy of aclidinium bromide, a long-acting anticholinergic bronchodilator, for the treatment of COPD. Twice-daily dosing of aclidinium leads to clinically important improvements in forced expiratory volume in 1 second, health status, use of rescue medication, day-time dyspnoea and exercise tolerance. The available studies also suggest an effect on night-time dyspnoea and exacerbation rate in patients with COPD. Aclidinium seems to have potential for a significant role in the future management of COPD.
AB - Long-acting bronchodilators are central for treatment of COPD. This short review provides an overview of studies evaluating the efficacy of aclidinium bromide, a long-acting anticholinergic bronchodilator, for the treatment of COPD. Twice-daily dosing of aclidinium leads to clinically important improvements in forced expiratory volume in 1 second, health status, use of rescue medication, day-time dyspnoea and exercise tolerance. The available studies also suggest an effect on night-time dyspnoea and exacerbation rate in patients with COPD. Aclidinium seems to have potential for a significant role in the future management of COPD.
M3 - Tidsskriftartikel
C2 - 25291997
VL - 176
SP - 1296
EP - 1299
JO - Ugeskrift for Laeger
JF - Ugeskrift for Laeger
SN - 0041-5782
IS - 28
ER -
ID: 137426804